143
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Potential Development of a Mobile Application for Gout Self-Management: What Support Do Patients Need?

, , &
Pages 2231-2238 | Published online: 01 Oct 2021

References

  • The Lancet Rheumatology. Big little lies: challenging misperceptions of gout. Lancet Rheum. 2019;1(2):e75. doi:10.1016/S2665-9913(19)30036-0.
  • Yu KH, Chen DY, Chen JH, et al. Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan. Int J Rheum Dis. 2018;21(4):772–787. doi:10.1111/1756-185X.13266
  • Kuo CF, Grainge MJ, See LC, et al. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther. 2015;17(1):13. doi:10.1186/s13075-015-0522-8
  • Chen Y, Tang Z, Huang Z, et al. The prevalence of gout in mainland China from 2000 to 2016: a systematic review and meta-analysis. J Public Health. 2017;25:521–529. doi:10.1007/s10389-017-0812-5
  • Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42. doi:10.1136/annrheumdis-2016-209707
  • Hui M, Carr A, Cameron S, et al. The british society for rheumatology guideline for the management of gout. Rheumatology. 2017;56(7):e1–e20. doi:10.1093/rheumatology/kex156
  • Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med. 2012;125(7):679–687. doi:10.1016/j.amjmed.2011.09.033
  • Zhang F. The Current Status and Influential Factors of Self-Management in Gout Patients. Qingdao: Qingdao University; 2017.
  • Liang GY. Analysis of Follow-Up Status and Exploration of the IL-17 Expresssion Level for Patients with Gout. Beijing: Peking Union Medical College; 2016.
  • Scott IA, Scuffham P, Gupta D, Harch TM, Borchi J, Richards B. Going digital: a narrative overview of the effects, quality and utility of mobile apps in chronic disease self-management. Aust Health Rev. 2020;44(1):62–82. doi:10.1071/AH18064
  • Najm A, Gossec L, Weill C, Benoist D, Berenbaum F, Nikiphorou E. Mobile health apps for self-management of rheumatic and musculoskeletal diseases: systematic literature review. JMIR mHealth uHealth. 2019;7(11):e14730. doi:10.2196/14730
  • NEWZOO. 2020 global mobile market report. 2020. Available from: https://resources.newzoo.com/hubfs/Reports/2020_Free_Global_Mobile_Market_Report.pdf?utm_campaign=Global%20Mobile%20Market%20Report%202020&utm_medium=email&_hsmi=95373037&_hsenc=p2ANqtz–MfoxwCCeNxDPb5sHydeesQX4GizTCG6JMzgWNbsCVJgjU4-t1WiRb_fjG3dRACxuepc25xLfDAyjPtz8qHIrvh2Zyzw&utm_content=95373037&utm_source=hs_automation. Accessed May 9, 2021.
  • Li XC. Analysis on Possibility of Mobile Apps on Gout/Hyperuricaemia: A New Management Model for Chronic Non-Infectious Disease. Chengdu: Sichuan University; 2016.
  • Huang C, Zhan YY, Liu XY, et al. Review on the application of mobile health in nursing. Chin J Nur. 2019;54(8):1264–1269. doi:10.3761/j.issn.0254-1769.2019.08.031
  • Wang XR, Ding YX, Wang BQ. Application effect and enlightenment of mobile-health APP in continuity care. Chin Nur Res. 2019;33(5):803–806. doi:10.12102/j.issn.1009-6493.2019.05.016
  • Xu XY, Wang JJ, Liu JP, Zhu PR, Luo WL. Research progress on application of mobile phone APP in health management. Chin Evid-Based Nur. 2018;4(10):888–890. doi:10.12102/j.issn.2095-8668.2018.10.006
  • Yin Y, Chen H. Letter to the editor: mobile applications for patients with gout in China. Clin Rheumatol. 2019;38(8):2281–2282. doi:10.1007/s10067-019-04622-1
  • Najm A, Nikiphorou E, Kostine M, et al. EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases. RMD Open. 2019;5(2):e001014. doi:10.1136/rmdopen-2019-001014
  • McCurdie T, Taneva S, Casselman M, et al. mHealth consumer apps: the case for user-centered design. Biomed Instrum Technol. 2012;46:(s2):49–56. doi:10.2345/0899-8205-46.s2.49
  • Neogi T, Jansen T, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789–1798. doi:10.1136/annrheumdis-2015-208237
  • Colaizzi PF. Psychological research as the phenomenologist’s view it. In: Existential Phenomenological Alternatives for Psychology. 1978:48–71.
  • Derksen C, Serlachius A, Petrie KJ, Dalbeth N. What say ye gout experts?” a content analysis of questions about gout posted on the social news website Reddit. BMC Musculoskelet Disord. 2017;18(1):488. doi:10.1186/s12891-017-1856-y
  • Yin RL. A Survey of Treatment Adherence to Urate-Lowering Therapy in Chinese Gout Patients and Its Influencing Factors. Nantong: Nantong University; 2017.
  • Li ZX, Li QH, Mo YQ, Liu HJ, Zheng DH, Dai L. Questionnaire survey evaluating gout-related diet control Knowledge on patients with gout. J Sun Yat-Sen Uni(Med Sci). 2015;36(2):306–312.
  • Rai SK, Choi HK, Choi SHJ, Townsend AF, Shojania K, De Vera MA. Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies. Rheumatology. 2018;57(7):1282–1292. doi:10.1093/rheumatology/kex530
  • Panginikkod S, Hashim R, Ufion AJA, et al. Knowledge gaps in gout management: a cross sectional survey among internal medicine residents. J Gen Intern Med. 2018;33(s2):S246–S246.
  • Liddle J, Roddy E, Mallen CD, et al. Mapping patients’ experiences from initial symptoms to gout diagnosis: a qualitative exploration. BMJ Open. 2015;5(9):e008323. doi:10.1136/bmjopen-2015-008323
  • Jimenez-Liñan LM, Edwards L, Abhishek A, Doherty M. Adequacy of online patient information resources on gout and potentially curative urate-lowering treatment. Arthritis Care Res (Hoboken). 2017;69(5):748–752. doi:10.1002/acr.22981
  • Johnston ME, Treharne GJ, Chapman PT, Stamp LK. Patient information about gout: an international review of existing educational resources. J Rheumatol. 2015;42(6):975–978. doi:10.3899/jrheum.141442
  • Howren A, Zusman EZ, Rai SK, Shojania K, De Vera MA. Prevalence, incidence, determinants, and impacts of depression and anxiety in gout: a systematic review. Arthritis Rheumatol. 2018;70:s9.
  • Singh JA, Cleveland JD. Gout and the risk of incident depression in older adults. Psychiatry Res. 2018;270:842–844. doi:10.1016/j.psychres.2018.10.067
  • Morgan J. Gout is not a life sentence: be informed. Lancet Rheum. 2019;1(3):e144. doi:10.1016/S2665-9913(19)30074-8
  • Kleinstauber M, Wolf L, Jones ASK, Dalbeth N, Petrie KJ. Internalized and anticipated stigmatization in patients with gout. ACR Open Rheumatol. 2020;2(1):11–17. doi:10.1002/acr2.11095
  • Yin R, Li L, Zhang G, et al. Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis. BMJ Open. 2018;8(4):e017542. doi:10.1136/bmjopen-2017-017542
  • Aung T, Myung G, FitzGerald JD. Treatment approaches and adherence to urate-lowering therapy for patients with gout. Patient Prefer Adherence. 2017;11:795–800. doi:10.2147/PPA.S97927